Tapewire

Nasdaq · USD

AQST

Aquestive Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5276
SEC CIK
0001398733
Parsed reports
319

Last 12 months

Inside the activity.

0 purchase rows · 15 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202607
Apr 202600
May 202601
Jun 202602
Jul 202602
Aug 202601
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 09, 2024 Filed Oct 2, 2024 18:15 UTC Amendment
Barber DanielPresident and CEO
Tax withholdingCommon Stock 56,824 $4.88 $277,301.12
Disclosure

SEC source: 0001214659-24-017009 · marketforms-67097.xml · nonDerivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 826,478

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .

Read SEC document
March 09, 2024 Filed Oct 2, 2024 18:14 UTC Amendment
Jung CassieSVP, Operations
Tax withholdingCommon Stock 14,120 $4.88 $68,905.60
Disclosure

SEC source: 0001214659-24-017008 · marketforms-67098.xml · nonDerivative · entry 3

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,066

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .

Read SEC document
March 08, 2024 Filed Mar 12, 2024 13:45 UTC
Schobel Alexander MarkChief Innovation/Tech Officer
SaleCommon Stock 25,000 $5.19 $129,685.00
Disclosure

SEC source: 0001214659-24-004389 · marketforms-65141.xml · nonDerivative · entry 1

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,040,371

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2023.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $5.00 to $5.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 10:36 UTC
Schobel Alexander MarkChief Innovation/Tech Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 41,250 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004307 · marketforms-64693.xml · derivative · entry 2

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,250

Underlying: Common Stock · 41,250 shares

Expires 2034-03-07

F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 10:36 UTC
Schobel Alexander MarkChief Innovation/Tech Officer
GrantCommon Stock 82,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004307 · marketforms-64693.xml · nonDerivative · entry 1

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,065,371

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:36 UTC
TOTH A ERNEST JRSVP, Chief Financial Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 60,000 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004308 · marketforms-64694.xml · derivative · entry 2

TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2034-03-07

F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:36 UTC
TOTH A ERNEST JRSVP, Chief Financial Officer
GrantCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004308 · marketforms-64694.xml · nonDerivative · entry 1

TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:36 UTC
BRAENDER LORI JSVP, General Counsel
GrantNon-Qualified Stock Option (right to buy) · Derivative 67,500 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004309 · marketforms-64690.xml · derivative · entry 2

BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,500

Underlying: Common Stock · 67,500 shares

Expires 2034-03-07

F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:36 UTC
BRAENDER LORI JSVP, General Counsel
GrantCommon Stock 135,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004309 · marketforms-64690.xml · nonDerivative · entry 1

BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,761

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Kraus Carl NChief Medical Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 56,250 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004306 · marketforms-64692.xml · derivative · entry 2

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 56,250 shares

Expires 2034-03-07

F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Kraus Carl NChief Medical Officer
GrantCommon Stock 112,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004306 · marketforms-64692.xml · nonDerivative · entry 1

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,500

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Barber DanielPresident and CEO
GrantNon-Qualified Stock Option (right to buy) · Derivative 363,900 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004305 · marketforms-64682.xml · derivative · entry 2

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,900

Underlying: Common Stock · 363,900 shares

Expires 2034-03-07

F2 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Barber DanielPresident and CEO
GrantCommon Stock 242,600 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004305 · marketforms-64682.xml · nonDerivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 883,302

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Jung CassieSVP, Operations
GrantNon-Qualified Stock Option (right to buy) · Derivative 50,625 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004304 · marketforms-65134.xml · derivative · entry 5

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,625

Underlying: Common Stock · 50,625 shares

Expires 2024-03-07

F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Jung CassieSVP, Operations
GrantCommon Stock 101,250 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004304 · marketforms-65134.xml · nonDerivative · entry 4

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,186

F3 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Boyd Peter E.See Remark
GrantNon-Qualified Stock Option (right to buy) · Derivative 43,125 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004303 · marketforms-64689.xml · derivative · entry 2

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,125

Underlying: Common Stock · 43,125 shares

Expires 2034-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:35 UTC
Boyd Peter E.See Remark
GrantCommon Stock 86,250 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004303 · marketforms-64689.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,998

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

F2 · balance_after: The original Form 4, filed on 3/9/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares for 59,532 shares owned when in fact 59,748 shares of the Issuer's common stock were owned. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 216 shares.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:34 UTC
Wargacki StephenSVP, Research & Development
GrantNon-Qualified Stock Option (right to buy) · Derivative 56,250 $0.00 Strike: $5.68 $0.00
Disclosure

SEC source: 0001214659-24-004302 · marketforms-64695.xml · derivative · entry 3

Wargacki Stephen · CIK 0001960165 · SVP, Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 56,250 shares

Expires 2034-03-07

F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 14:34 UTC
Wargacki StephenSVP, Research & Development
GrantCommon Stock 112,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004302 · marketforms-64695.xml · nonDerivative · entry 2

Wargacki Stephen · CIK 0001960165 · SVP, Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,919

F3 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 16:30 UTC
Schobel Alexander MarkChief Innovation/Tech Officer
GrantPerformance Stock Units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010922 · marketforms-61881.xml · derivative · entry 1

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
TOTH A ERNEST JRSVP, Chief Financial Officer
GrantPerformance Stock Units · Derivative 70,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010923 · marketforms-61879.xml · derivative · entry 1

TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
BRAENDER LORI JSVP, General Counsel
GrantPerformance Stock Units · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010927 · marketforms-61884.xml · derivative · entry 1

BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
Barber DanielPresident and CEO
GrantPerformance Stock Units · Derivative 223,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010926 · marketforms-61886.xml · derivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,500

Underlying: Common Stock · 223,500 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
Boyd Peter E.See Remark
GrantPerformance Stock Units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010925 · marketforms-61885.xml · derivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
Marshall Ken W.SVP, Chief Commercial Officer
GrantPerformance Stock Units · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010921 · marketforms-61882.xml · derivative · entry 1

Marshall Ken W. · CIK 0001740092 · SVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
Kraus Carl NChief Medical Officer
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010919 · marketforms-62126.xml · nonDerivative · entry 1

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
Wargacki StephenSVP, Research & Development
GrantPerformance Stock Units · Derivative 67,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010924 · marketforms-61880.xml · derivative · entry 1

Wargacki Stephen · CIK 0001960165 · SVP, Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,500

Underlying: Common Stock · 67,500 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
August 09, 2023 Filed Aug 9, 2023 20:30 UTC
Jung CassieSVP, Operations
GrantPerformance Stock Units · Derivative 55,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-010920 · marketforms-61883.xml · derivative · entry 1

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each performance-based stock unit ("PSU") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 12:26 UTC GrantStock Option (Right to Purchase) · Derivative 25,000 $0.00 Strike: $2.02 $0.00
Disclosure

SEC source: 0001214659-23-008794 · marketforms-61960.xml · derivative · entry 2

COSTA SANTO J · CIK 0001013419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Costa's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 16:28 UTC
Krop JulieDirector
GrantStock Option (Right to Purchase) · Derivative 25,000 $0.00 Strike: $2.02 $0.00
Disclosure

SEC source: 0001214659-23-008797 · marketforms-61961.xml · derivative · entry 1

Krop Julie · CIK 0001643127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 12:26 UTC GrantStock Option (Right to Purchase) · Derivative 25,000 $0.00 Strike: $2.02 $0.00
Disclosure

SEC source: 0001214659-23-008795 · marketforms-61962.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 16:24 UTC
Cochran JohnDirector
GrantStock Option (Right to Purchase) · Derivative 25,000 $0.00 Strike: $2.02 $0.00
Disclosure

SEC source: 0001214659-23-008793 · marketforms-61959.xml · derivative · entry 2

Cochran John · CIK 0001406773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 12:27 UTC GrantStock Option (right to purchase) · Derivative 25,000 $0.00 Strike: $2.02 $0.00
Disclosure

SEC source: 0001214659-23-008796 · marketforms-61963.xml · derivative · entry 1

MORRIS TIMOTHY E · CIK 0001191286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 21, 2023 Filed Jun 23, 2023 13:41 UTC GrantStock Option (Right to Purchase) · Derivative 25,000 $0.00 Strike: $2.02 $0.00
Disclosure

SEC source: 0001214659-23-008799 · marketforms-61958.xml · derivative · entry 2

BROWN GREGORY B · CIK 0001373585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
May 05, 2023 Filed May 5, 2023 16:00 UTC
Schobel Alexander MarkChief Innovation/Tech Officer
GrantPerformance Stock Units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006558 · marketforms-61240.xml · derivative · entry 1

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
May 05, 2023 Filed May 5, 2023 20:00 UTC
TOTH A ERNEST JRSVP, Chief Financial Officer
GrantPerformance Stock Units · Derivative 70,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006559 · marketforms-61241.xml · derivative · entry 1

TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
May 05, 2023 Filed May 5, 2023 20:00 UTC
Wargacki StephenSVP, Research & Development
GrantPerformance Stock Units · Derivative 67,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006560 · marketforms-61242.xml · derivative · entry 1

Wargacki Stephen · CIK 0001960165 · SVP, Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,500

Underlying: Common Stock · 67,500 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
May 05, 2023 Filed May 5, 2023 20:00 UTC
BRAENDER LORI JSVP, General Counsel
GrantPerformance Stock Units · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006557 · marketforms-61237.xml · derivative · entry 1

BRAENDER LORI J · CIK 0001752955 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
May 05, 2023 Filed May 5, 2023 20:00 UTC
Barber DanielPresident and CEO
GrantPerformance Stock Units · Derivative 223,500 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006556 · marketforms-61227.xml · derivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,500

Underlying: Common Stock · 223,500 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
May 05, 2023 Filed May 5, 2023 20:00 UTC
Marshall Ken W.SVP, Chief Commercial Officer
GrantPerformance Stock Units · Derivative 75,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006553 · marketforms-61239.xml · derivative · entry 1

Marshall Ken W. · CIK 0001740092 · SVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
May 05, 2023 Filed May 5, 2023 20:00 UTC
Jung CassieSVP, Operations
GrantPerformance Stock Units · Derivative 55,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006554 · marketforms-61238.xml · derivative · entry 1

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
May 05, 2023 Filed May 5, 2023 20:00 UTC
Boyd Peter E.See Remark
GrantPerformance Stock Units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-006555 · marketforms-61236.xml · derivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2026-05-05

F1 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

F1 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of Aquestive ("Company") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period.

Read SEC document
March 10, 2023 Filed Mar 11, 2024 14:35 UTC
Jung CassieSVP, Operations
Tax withholdingCommon Stock 1,365 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-004304 · marketforms-65134.xml · nonDerivative · entry 3

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,936

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

F2 · balance_after: The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,173 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,490 shares reflecting share withheld for the payment of taxes.

Read SEC document
March 10, 2023 Filed Mar 11, 2024 14:34 UTC
Wargacki StephenSVP, Research & Development
Tax withholdingCommon Stock 1,981 $0.79 $1,572.32
Disclosure

SEC source: 0001214659-24-004302 · marketforms-64695.xml · nonDerivative · entry 1

Wargacki Stephen · CIK 0001960165 · SVP, Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,419

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

F2 · balance_after: The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,107 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,556 shares reflecting share withheld for the payment of taxes.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 15:07 UTC
Schobel Alexander MarkChief Innovation/Tech Officer
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-003692 · marketforms-59529.xml · nonDerivative · entry 1

Schobel Alexander Mark · CIK 0001406836 · Chief Innovation/Tech Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 982,871

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 20:05 UTC
TOTH A ERNEST JRSVP, Chief Financial Officer
GrantCommon Stock 140,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-003688 · marketforms-59530.xml · nonDerivative · entry 1

TOTH A ERNEST JR · CIK 0001280273 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 20:07 UTC
Boyd Peter E.See Remark
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-003695 · marketforms-59523.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,532

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 20:07 UTC
Marshall Ken W.SVP, Chief Commercial Officer
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-003694 · marketforms-59527.xml · nonDerivative · entry 1

Marshall Ken W. · CIK 0001740092 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 20:07 UTC
Jung CassieSVP, Operations
GrantCommon Stock 110,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-003693 · marketforms-59531.xml · nonDerivative · entry 1

Jung Cassie · CIK 0001960154 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,747

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2023 Filed Mar 9, 2023 20:06 UTC
Barber DanielPresident and CEO
GrantCommon Stock 447,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-003691 · marketforms-59518.xml · nonDerivative · entry 1

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 640,702

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.